Popular antidepressant recalled over high levels of a cancer-causing compound
The FDA has recalled certain bottles of duloxetine across the United States. The drug manufacturer issued a voluntary recall after tests found elevated levels of a nitrosamine impurity. This compound is linked to potential cancer risks.
What changed
The specific drug name duloxetine has been identified as the generic version of Cymbalta.
Live updates
-
Breckenridge Pharmaceuticals Recalls Duloxetine Over Cancer-Linked Impurity
confidence 100%The FDA has recalled certain bottles of duloxetine across the United States. The drug manufacturer issued a voluntary recall after tests found elevated levels of a nitrosamine impurity. This compound is linked to potential cancer risks.
What's confirmed:
- Breckenridge Pharmaceuticals voluntarily recalled several lots of duloxetine.
- The recall involves an impurity identified as a nitrosamine.
- Testing showed higher-than-recommended amounts of a cancer-linked impurity.
- The recall is occurring across the United States.
-
FDA Recalls Nearly 375,000 Bottles of Duloxetine Over Carcinogen Risk
confidence 90%The FDA has recalled a popular antidepressant due to high levels of a potentially cancer-causing impurity. Breckenridge Pharmaceuticals is recalling its generic version of Cymbalta. The impurity identified in the medication is a nitrosamine.
What's confirmed:
- The FDA recalled nearly 375,000 bottles of the antidepressant duloxetine.
- The recall was triggered by high levels of a potentially cancer-causing impurity.
- The impurity detected in the drug is a nitrosamine.
- Breckenridge Pharmaceuticals is recalling the generic version of Cymbalta.